Investors Warned At Morgan Stanley Dinner About Stealth Drug Price Controls

Watch out for government to take a “back door” approach to stealth drug price controls. Such was the topic recently discussed at a Morgan Stanley dinner and put in report form, which was reviewed by ValueWalk. Political rancor regarding a single payer system or overt price controls are likely to be a smokescreen to pressure the back door solution, those attending the March 23 dinner were told. Plus there is the “threat” of a little known payment committee, the “death panel,” that could come into play. The report comes as Evercore ISI recently predicted that drug price controls are unlikely.

Stealth drug price controls likely to be...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here